Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:39
Precision BioSciences Total Assets (Quarterly) : 120.38M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 120.38M |
| June 30, 2026 | 125.92M |
| March 31, 2026 | 143.89M |
| December 31, 2025 | 154.42M |
| September 30, 2025 | 93.51M |
| June 30, 2025 | 108.93M |
| March 31, 2025 | 124.41M |
| December 31, 2024 | 136.39M |
| September 30, 2024 | 153.26M |
| June 30, 2024 | 165.80M |
| March 31, 2024 | 184.74M |
| December 31, 2023 | 159.78M |
| September 30, 2023 | 164.34M |
| June 30, 2023 | 181.70M |
| March 31, 2023 | 204.50M |
| December 31, 2022 | 238.17M |
| September 30, 2022 | 271.73M |
| June 30, 2022 | 297.16M |
| Date | Value |
|---|---|
| March 31, 2022 | 181.35M |
| December 31, 2021 | 211.50M |
| September 30, 2021 | 227.20M |
| June 30, 2021 | 230.11M |
| March 31, 2021 | 262.32M |
| December 31, 2020 | 150.16M |
| September 30, 2020 | 168.69M |
| June 30, 2020 | 184.19M |
| March 31, 2020 | 214.20M |
| December 31, 2019 | 235.23M |
| September 30, 2019 | 260.30M |
| June 30, 2019 | 271.92M |
| March 31, 2019 | 166.80M |
| December 31, 2018 | 138.60M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 72.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.60M |
| Shareholders Equity (Quarterly) | 51.78M |
| Debt to Equity Ratio | 0.5354 |
| Current Ratio | 10.47 |
| Net Debt Paydown Yield | 0.20% |